GLP3 Retatrutide

GLP 3 Retatrutide | Triple Agonist Research Peptide

Retatrutide (LY3437943) is a synthetic research peptide developed as a triple receptor agonist, targeting GLP-1, GIP and glucagon receptors involved in metabolic regulation and energy balance.

Research into Retatrutide focuses on its interaction with these three hormonal pathways, particularly their roles in appetite regulation, glucose metabolism, energy expenditure and body weight regulation.

Clinical investigations have explored Retatrutide’s effects on obesity, insulin sensitivity, metabolic health and weight management through its unique triple agonist mechanism.

Product Highlights

• Synthetic Retatrutide (LY3437943) research peptide
• Triple GLP-1, GIP and glucagon receptor agonist
• Studied for appetite regulation and metabolic function
• Investigated in glucose metabolism and energy balance
• Explored in obesity and weight management research

Certificate of Analysis

View Certificate of Analysis (RT10)
View Certificate of Analysis (RT20)
View Certificate of Analysis (RT30)

Investigational compound. Not approved for human consumption or therapeutic use.